Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 29 Feb 2024 for Aurinia Pharmaceuticals Inc., €28k. Read the official filing
Filing timeline
BuySaleVolker Knappertz
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Volker Knappertz: trading record in brief
Filings by Volker Knappertz span 2 companies, the busiest being Aurinia Pharmaceuticals Inc. and GW Pharmaceuticals PLC. In total, 4 filings cover trades dated from 5 May 2021 to 27 February 2024.
Every open-market trade on record is a sale: 2 sales worth €156k. Outside the open market, there are 1 share grant. Since January 2024: no purchases and 2 sales on the market.
The latest filing, published on 29 February 2024, reports an open-market sale of €28k in Aurinia Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Volker Knappertz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
4,930 shares@ US$6.1017.8% of flowCommon StockSEC:0001600620-24-000028:0
25,146 shares@ US$5.4882.2% of flowCommon StockSEC:0001600620-24-000022:0
191,462 shares0Common StockSEC:0001628280-23-006527:0
92,412 sharesOrdinary SharesSEC:0000899243-21-018663:0
4 of 4 declarations
